infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 8 of 688 articles from: Treatment issues

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • Vertex urges CDC to recommend hep C screening, to nudge `second tsunami` of patients

    EATG / 03 February 2011

  • Manufacturer Recalls Alcohol Swab Products Packaged with Fuzeon, Other Meds

    AIDSmeds / 20 January 2011

  • New drugs take aim at hepatitis C, spur debate on whether to test baby boomers

    Canadian Press / 18 January 2011

  • Peregrine Initiates Randomized Phase II Trial of Bavituximab in Chronic Hepatitis C

    Market Wire / 10 January 2011

  • Bristol-Myers Squibb and Pharmasset Enter into a Clinical Collaboration Agreement for Proof of Concept Combination Study in Patients Chronically Infected with Hepatitis C

    Business Wire / 10 January 2011

  • Merck Beats Vertex to FDA Hep C Filing

    The Street / 07 January 2011

  • Pharmasset Reports Positive Results from its HCV Clinical Programs

    Pharmasset / 06 January 2011

  • Anadys Pharmaceuticals Initiates Phase IIb Study of ANA598 in HCV Patients

    PR Newswire / 05 January 2011

← Prev1...6566676869Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
      • Transmission and prevention
      • Diagnosis and monitoring
      • Disease course and symptoms
      • HCV and coinfections
      • Living with HCV
      • Treatment issues
      • Side effects
      • Therapies
      • Liver transplants
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2022. All rights reserved. We are not responsible for the content of external websites.

Company limited by guarantee. Registered in England & Wales, number: 2707596. Registered charity, number: 1011220

Infohep has been supported by a grant from Gilead Sciences Europe Ltd. Our funder has had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

infohep is produced by NAM. Find out more about NAM

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//